Abstract
Coronavirus disease 2019 (COVID-19) is associated with significant hypercoagulability. However, despite prophylactic anticoagulation, critically ill patients with this condition develop thromboses. This forum discusses the lungs as the epicenter for the hemostatic issues, puts forward a proposal for staging COVID-19 coagulopathy based on available diagnostic markers, and suggest considering current and future treatment options based on these different stages.
Author supplied keywords
Cite
CITATION STYLE
Thachil, J., Cushman, M., & Srivastava, A. (2020, July 1). A proposal for staging COVID-19 coagulopathy. Research and Practice in Thrombosis and Haemostasis. Blackwell Publishing Ltd. https://doi.org/10.1002/rth2.12372
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
